• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在公众咨询后,国家统一卫生系统技术纳入委员会发布的建议被撤销。

Reversal of the recommendations issued by the National Commission for the Incorporation of Technologies in SUS after Public Consultations.

作者信息

Lopes Sarah Gomes Pitta, Luiza Vera Lúcia, Silva Rondineli Mendes da

机构信息

Conselho Regional de Farmácia do Estado do Rio de Janeiro. R. Afonso Pena 115, Tijuca. 20270-244 Rio de Janeiro RJ Brasil.

Escola Nacional de Saúde Pública Sérgio Arouca, Fundação Oswaldo Cruz. Rio de Janeiro RJ Brasil.

出版信息

Cien Saude Colet. 2023 Feb;28(2):561-573. doi: 10.1590/1413-81232023282.10382022. Epub 2022 Sep 2.

DOI:10.1590/1413-81232023282.10382022
PMID:36651407
Abstract

The work analyzed the effect of Public Consultations (PC) and their contributions to the recommendations of the National Commission for the Incorporation of Technologies (CONITEC). This is a descriptive and retrospective study with a qualitative-quantitative approach using a secondary data source of public access, between 2012 and 2017. A database was developed to characterize the PC of medications and their contributions, which allowed the identification of cases of reversals between the preliminary and final recommendation of CONITEC. We analyzed the contributions in cases of reversal for characterization of argumentative axes and type of basis. Of the 307 demands for incorporation of medications, 205 went through PC, with 23,894 contributions. The reversal of the recommendations occurred in 9% of the open PC (15 medications), all in the sense of non-incorporation for incorporation. Main argumentative axes dealt with clinical benefits and minor adverse events, with prevalence of the submission of clinical experiences and opinions. Advances in the processes of incorporation of technologies in the SUS by performing PC were found and the challenge that decision makers face in institutional spaces for the improvement of social participation to strengthen the public benefit was clear.

摘要

该研究分析了公众咨询(PC)的效果及其对国家技术纳入委员会(CONITEC)建议的贡献。这是一项描述性回顾性研究,采用定性定量方法,利用2012年至2017年期间可公开获取的二手数据源。开发了一个数据库来描述药物的公众咨询情况及其贡献,从而能够识别CONITEC初步建议和最终建议之间的反转案例。我们分析了反转案例中的贡献,以确定论证轴和依据类型。在307项药物纳入申请中,205项经过了公众咨询,收到了23894份意见。公开的公众咨询中有9%(15种药物)的建议发生了反转,均是从不纳入转为纳入。主要论证轴涉及临床益处和轻微不良事件,提交的临床经验和意见占多数。通过开展公众咨询,发现了统一卫生系统(SUS)技术纳入流程中的进展,并且明确了决策者在机构层面提高社会参与度以增强公共利益时所面临的挑战。

相似文献

1
Reversal of the recommendations issued by the National Commission for the Incorporation of Technologies in SUS after Public Consultations.在公众咨询后,国家统一卫生系统技术纳入委员会发布的建议被撤销。
Cien Saude Colet. 2023 Feb;28(2):561-573. doi: 10.1590/1413-81232023282.10382022. Epub 2022 Sep 2.
2
Incorporation of new medicines by the National Commission for Incorporation of Technologies, 2012 to June 2016.技术纳入国家委员会对新药的纳入情况,2012年至2016年6月
Cien Saude Colet. 2017 Aug;22(8):2513-2525. doi: 10.1590/1413-81232017228.02002017.
3
Does patient and public involvement impact public health decision-making? A 10 year retrospective analysis of public consultation in Brazil.患者和公众参与是否会影响公共卫生决策?对巴西 10 年来公共咨询的回顾性分析。
Health Res Policy Syst. 2023 Jul 12;21(1):72. doi: 10.1186/s12961-023-01018-1.
4
[The incorporation of nusinersen by the Brazilian Unified National Health System: critical thoughts on the institutionalization of health technology assessment in Brazil].[巴西统一国家卫生系统纳入诺西那生:对巴西卫生技术评估制度化的批判性思考]
Cad Saude Publica. 2019 Aug 29;35(8):e00099619. doi: 10.1590/0102-311X00099619.
5
Patient and public involvement in health technology decision-making processes in Brazil.巴西卫生技术决策过程中的患者和公众参与。
Rev Saude Publica. 2020 Dec 11;54:136. doi: 10.11606/s1518-8787.2020054002453. eCollection 2020.
6
Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.巴西国家 HTA 机构决策过程面临的挑战:操作程序、证据使用和建议。
Health Res Policy Syst. 2018 May 11;16(1):40. doi: 10.1186/s12961-018-0319-8.
7
Social participation in the health technology incorporation process into Unified Health System.社会参与卫生技术纳入统一卫生系统的过程。
Rev Saude Publica. 2019 Dec 20;53:109. doi: 10.11606/S1518-8787.2019053001420. eCollection 2019.
8
Health technology reassessment in the Brazilian public health system: Analysis of the current status.巴西公共卫生系统中的卫生技术再评估:现状分析。
PLoS One. 2019 Jul 29;14(7):e0220131. doi: 10.1371/journal.pone.0220131. eCollection 2019.
9
[Does the pharmaceutical industry interfere in the sustainability of the public health system in Brazil? A reflection on the pressure for the incorporation of medicines].制药行业是否干扰了巴西公共卫生系统的可持续性?关于药品纳入压力的思考
Cad Saude Publica. 2022 Jul 25;38(7):e00233321. doi: 10.1590/0102-311XPT233321. eCollection 2022.
10
Exploring the COVID-19 Pandemic's Impact on the Health Technology Assessment Process of the National Commission for the Incorporation of Technologies Into the Brazilian Health System.探索 COVID-19 大流行对巴西国家技术融入卫生系统委员会健康技术评估过程的影响。
Value Health Reg Issues. 2023 Sep;37:18-22. doi: 10.1016/j.vhri.2023.04.002. Epub 2023 May 15.